Kelly, CP, Pothoulakis, C, LaMont, JT.
Clostridium difficile colitis. N Engl ] Med
McDonald, LC, Killgore, GE, Thompson, A, et al.
An epidemic, toxin gene-variant strain of Clostridium difficile
. N Eng J Med
Warny, M, Pepin, J, Fang, A, et al.
Increased toxins A and B production by an emerging strain of Clostridium difficile associated with outbreaks of severe disease in North America and Europe. Lancet
Musher, DM, Aslam, S, Logan, N, et al.
Relatively poor outcome after treatment of Clostridium difficile colitis with metronidazole. Clin Infect Dis
Pepin, J, Alary, ME, Valiquette, L
Increasing risk of relapse after treatment of Clostridium difficile colitis in Quebec, Canada. Clin Infect Dis
Belmares, J, Gerding, DN, Parada, JP, et al.
Outcome of metronidazole therapy for Clostridium difficile disease and correlation with a scoring system. J Infect
Zar, FA, Bakkanagari, SR, Moorthi, KM, et al.
A comparison of vancomycin and metronidazole for the treatment of Clostridium difficile-associated diarrhea, stratified by disease severity. Clin Infect Dis
Cohen, SH, Gerding, DN, Johnson, S, et al.
Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the Society for Healthcare Epidemiology of America (SHEA) and the Infectious Diseases Society of America (IDSA). Infect Control Hosp Epidemiol
Bloomfield, MG, Sherwin, JC, Gkrania-Klotsas, E. Risk factors for mortality in Clostridium difficile infection in the general hospital population: a systematic review. J Hosp Infect